entertainment -WSS

entertainment

author：hotspot 2025-10-02 01:39:04 Page View：3

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： A cyberattack has disrupted hospitals and health care in several states
Next article： Medicare proposal to cover medical devices draws a mixed reaction

knowledge

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

OTC birth control: A brief history of over the counter pill design

Illustration:AlexHogan/STAT;Photo:CourtesyPerrigoIt’snoteverydaythatamarketingteamistaskedwithdesign

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

The boys, now 6, who are gene therapy’s ‘edge case’ problem

HiramSecrist(left),whohasDuchennemusculardystrophy,withhismother,KristenSecrist(center),andhisgrandm

entertainment

explore

knowledge

The boys, now 6, who are gene therapy’s ‘edge case’ problem